{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:12:57Z","timestamp":1791267177156,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.ejphar.2009.01.005","type":"journal-article","created":{"date-parts":[[2009,1,18]],"date-time":"2009-01-18T04:03:03Z","timestamp":1232251383000},"page":"255-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Hydrangeic acid from the processed leaves of Hydrangea macrophylla var. thunbergii as a new type of anti-diabetic compound"],"prefix":"10.1016","volume":"606","author":[{"given":"Hailong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seikou","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2009.01.005_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1248\/jhs.51.21","article-title":"Characteristics of circadian gene expressions in mice white adipose tissue and 3T3-L1 adipocytes","volume":"51","author":"Aoyagi","year":"2005","journal-title":"J. Health Sci."},{"key":"10.1016\/j.ejphar.2009.01.005_bib2","doi-asserted-by":"crossref","first-page":"R1220","DOI":"10.1152\/ajpregu.00397.2004","article-title":"Adiponectin inhibits LPS-induced NF-\u03baB activation and IL-6 production and increases PPAR\u03b32 expression in adipocytes","volume":"288","author":"Ajuwon","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2009.01.005_bib3","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1345\/aph.1K013","article-title":"Evolution of peroxisome proliferator-activated receptor agonists","volume":"41","author":"Chang","year":"2007","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejphar.2009.01.005_bib4","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0024-3205(00)00796-7","article-title":"Troglitazone inhibits the expression of inducible nitric oxide synthase in adipocytes in vitro and in vivo: Study in 3T3-L1 cells and Otsuka Long\u2013Evans Tokushima Fatty rats","volume":"67","author":"Dobashi","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2009.01.005_bib5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1248\/bpb.29.110","article-title":"Ginsenoside 20(S)-protopanaxatriol (PPT) activates peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) in 3T3-L1 adipocytes","volume":"29","author":"Han","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2009.01.005_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.med.0000261735.91562.06","article-title":"Pharmacological interventions in the prevention of type 2 diabetes","volume":"14","author":"Henness","year":"2007","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.ejphar.2009.01.005_bib7","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/toxsci\/68.1.226","article-title":"Rodent carcinogenicity with the thiazolidinedione antidiabetic agent trogitazone","volume":"68","author":"Herman","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2009.01.005_bib8","first-page":"42300","article-title":"Disruption of microtubules ablates the specificity of insulin signaling to GLUT4 translocation in 3T3-L1 adipocytes","volume":"280","author":"Huang","year":"2005","journal-title":"J. Biochem."},{"key":"10.1016\/j.ejphar.2009.01.005_bib9","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2337\/diabetes.52.7.1655","article-title":"Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors","volume":"52","author":"Iwaki","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2009.01.005_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptor","volume":"26","author":"Kadowaki","year":"2005","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejphar.2009.01.005_bib11","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1210\/en.2004-0180","article-title":"Transcription suppression of peroxisome proliferator-activated receptor \u03b32 gene expression by tumor necrosis factor \u03b1 via an inhibition of CCAAT\/enhancer-binding protein \u03b4 during the early stage of adipocyte differentiation","volume":"145","author":"Kudo","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2009.01.005_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0968-0896(00)00215-7","article-title":"Antioxidant constituents from rhubarb: structural requirements of stilbenes for the activity and structures of two new anthraquinone glucosides","volume":"9","author":"Matsuda","year":"2001","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejphar.2009.01.005_bib13","doi-asserted-by":"crossref","first-page":"E973","DOI":"10.1152\/ajpendo.00549.2004","article-title":"Adipocytes with increased hexosamine flux exhibit insulin resistance, increased glucose uptake, and increased synthesis and storage of lipid","volume":"288","author":"McClain","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2009.01.005_bib14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0169-409X(02)00093-5","article-title":"Troglitazone: the discovery and development of a novel therapy for the treatment of type 2 diabetes mellitus","volume":"54","author":"Parker","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejphar.2009.01.005_bib15","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1093\/jn\/137.12.2668","article-title":"Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes","volume":"137","author":"Rayalam","year":"2007","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejphar.2009.01.005_bib16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.lfs.2006.10.021","article-title":"Ginsenoside Rb1 promotes adipogenesis in 3T3-L1 cells by enhancing PPAR\u03b32 and C\/EBP\u03b1 gene expression","volume":"80","author":"Shang","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2009.01.005_bib17","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1210\/endo.137.11.8895337","article-title":"Troglitazone enhances differentiation, basal glucose uptake, and GLUT1 protein levels in 3T3-L1 adipocytes","volume":"137","author":"Tafuri","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2009.01.005_bib18","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1101\/gad.8.10.1224","article-title":"mPPAR\u03b32: tissue-specific regulator of an adipocyte enhancer","volume":"8","author":"Tontonoz","year":"1994","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejphar.2009.01.005_bib19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1254\/jphs.FMJ04008X2","article-title":"Nuclear receptors as targets for drug development: molecular mechanisms for regulation of obesity and insulin resistance by peroxisome proliferator-activated receptor \u03b3, CREB-binding protein, and adiponectin","volume":"97","author":"Tsuchida","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2009.01.005_bib20","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.lfs.2008.03.003","article-title":"Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin","volume":"82","author":"Yang","year":"2008","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2009.01.005_bib21","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1248\/cpb.44.1890","volume":"44","author":"Yoshikawa","year":"1996","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejphar.2009.01.005_bib22","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1016\/j.bmcl.2007.06.027","article-title":"New type of anti-diabetic compounds from the processed leaves of Hydrangea macrophylla var. thunbergii (Hydrangeae Dulcis Folium)","volume":"17","author":"Zhang","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909000193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299909000193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:09:37Z","timestamp":1757974177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299909000193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":22,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0014299909000193"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.01.005","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrangeic acid from the processed leaves of Hydrangea macrophylla var. thunbergii as a new type of anti-diabetic compound","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2009.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}